3.33 USD
+0.12 (+3.74%)
3.35 USD
+0.02 (+0.6%)
ChartMill assigns a Buy % Consensus number of 49% to IRWD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.55. This target is -23.42% below the current price.
IRWD was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about IRWD.
In the previous month the buy percentage consensus was at a similar level.
IRWD was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-11 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-15 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-04-15 | Jefferies | Downgrade | Buy -> Hold |
| 2025-04-14 | Leerink Partners | Maintains | Market Perform -> Market Perform |
| 2025-01-30 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-01-22 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-09-09 | Leerink Partners | Initiate | Market Perform |
| 2024-08-09 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-08-09 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-05-10 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-03-01 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-02-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-01-17 | Craig-Hallum | Initiate | Buy |
| 2023-12-14 | Wells Fargo | Initiate | Overweight |
| 2023-09-28 | JMP Securities | Initiate | Market Outperform |
| 2023-05-23 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2022-08-16 | Wells Fargo | Maintains | Equal-Weight |
| 2022-04-22 | Piper Sandler | Initiate | Overweight |
| 2021-10-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-07-16 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-02-22 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-02-19 | Morgan Stanley | Maintains | Equal-Weight |
IRONWOOD PHARMACEUTICALS INC / IRWD FAQ
What is the price target for IRWD stock?
9 analysts have analysed IRWD and the average price target is 2.55 USD. This implies a price decrease of -23.42% is expected in the next year compared to the current price of 3.33.
What is the consensus rating for IRWD stock?
The consensus rating for IRONWOOD PHARMACEUTICALS INC (IRWD) is 48.8889 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
What is the number of analysts for IRWD stock?
The number of analysts covering IRONWOOD PHARMACEUTICALS INC (IRWD) is 9.